FDA Issues New Draft Guidance Documents

This entry was posted in FDA Guidance, Social Media, Thoughts. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Our colleagues at Dose of Digital have assembled two sets of key takeaways from Tuesday’s draft guidance documents on “Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation about prescription Drugs and Medical Devices” and “Internet/Social Media Limitations – Presenting Risk And Benefit Information for Prescription Drugs and Medical Devices”. The examples provided in the draft documents provide illuminating examples of the FDA’s thinking for Pharma companies attempting to participate in the world of Social Media, as we wait for the full and final agency guidance, expected later this year. Well worth a look.

Leave a Reply

Share |